 Avalon GloboCare Corp NASDAQ:AVCO told investors it was well positioned to execute on its growth strategy this year as the company highlighted it had partnered with world-renowned research centers and universities. In a year-end update, the clinical stage, cell therapy company noted its new collaboration with the University of Pittsburgh Medical Center UPMC to develop new cancer immunotherapy approaches and streamline manufacturing processes. 